Art

J-GLOBAL ID：200902264808606126   Reference number：09A0178166

Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics

血液透析患者におけるolmesartan medoxomilの薬物動態:その薬物動態に対する透析の小効果

Author (10)： TANAKA Hirotaka (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  NAGASAWA Yasuyuki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  MATSUI Isao (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  HAMANO Takayuki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  IWATANI Hirotsugu (Osaka Kouseinenkin Hospital, Osaka, JPN) ,  KAWADA Noritaka (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  HORIO Masaru (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  ITO Takahito (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  ISAKA Yoshitaka (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  IMAI Enyu (Osaka Univ. Graduate School of Medicine, Osaka, JPN)
Material： Clinical and Experimental Nephrology  (Clin Exp Nephrol)
Volume： 13  Issue： 1  Page： 61-65  Publication year： Feb. 2009 
JST Material Number： L3173A  ISSN： 1342-1751  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0178166&from=J-GLOBAL&jstjournalNo=L3173A") }}

JST classification (2)： Other therapies for urogenital diseases  (GM05040R) ,  Clinical application of vasoactive drugs and hypotensive drugs  (GW07050U)

Substance index (1)： Olmesartan medoxomil

Reference (13)：

• SCHMIEDER, RE. Mechanisms for the clinical benefits of angiotensin II receptor blockers. Am J Hypertens. 2005, 18, 5 Pt 1, 720-730
• SICA, DA. Renal handling of angiotensin receptor blockers : clinical relevance. Curr Hypertens Rep. 2003, 5, 4, 337-339
• PFISTER, M. Pharmacokinetics and haemodynamics of candesartan cilexetil in hypertensive patients on regular haemodialysis. Br J Clin Pharmacol. 1999, 47, 6, 645-651
• TAKAHASHI, A. Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis-a randomized study. Nephrol Dial Transplant. 2006, 21, 9, 2507-2512
• PUN, PH. Predictors of survival after cardiac arrest in out-patient hemodialysis clinics. Clin J Am Soc Nephrol. 2007, 2, 3, 491-500

Terms in the title (3)： 血液透析患者 ,  薬物動態 ,  透析